Next Thursday, Fieldfisher are proud to be presenting Fifty Shades of Pain – a conference focusing on major issues associated with pain, including pain management and the dilemma of separating physical and psychological pain symptomology.
We’d like to take this opportunity to focus on one of the speakers at the conference, Dr Glyn R Towlerton, who will be giving a talk on the Nuts and bolts of treatment options. This talk will focus on the available techniques for treating pain and how they would be expected to be administered.
Dr Towlerton trained as an undergraduate in medicine at St. Bartholomew’s Hospital, London. He read for a BSc in experimental pathology and was awarded the Award of Merit, before qualifying as a Doctor with distinction in medicine in 1990. He commenced training in postgraduate medical specialities at the Royal Brompton Hospital & Hammersmith Hospital before gaining Membership of the Royal College of Physicians in 1992. He further specialised in Anaesthetics & Pain Medicine & was awarded Fellowship of the Royal College of Anaesthetists in 1995. He undertook fellowships in Sydney, Australia & Seattle, USA before taking up his substantive NHS appointment at Chelsea & Westminster Teaching Hospital, London in 2000. At Chelsea & Westminster Hospital he lead the Clinical Pain Management team.
He has particular expertise in treating lumbar, sciatica, neck and shoulder pain. He has treated many elite athletes from a wide range of sports for over a decade. His special interests include spinal interventional procedures and injections and spinal cord stimulation.
The 50 Shades of Pain conference takes place at Riverbank House, London Bridge, London, next Thursday 19th March.
SOURCE: Personal Injury Blog – Read entire story here.
Related posts:
New 20mph traffic zones to be trialled in London
Family of Aberystwyth woman launch appeal for information about her death, 26th March 2015
"Cold, getting warmer, hot": New app helps blind people find each other
The Supreme Court Eviscerates Preemption In Branded Drug Lawsuits
